AcquisitionOther

Ocuphire Pharma, Inc. acquired Opus Genetics, Inc.,

Name: Ocuphire Pharma, Inc. acquired Opus Genetics, Inc.,
Start: 2024-10-22

Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.

Deal tape row

Ocuphire Pharma, Inc. -> Opus Genetics, Inc.,

“Opus Genetics has created a compelling pipeline of transformative therapies for patients with inherited retinal diseases, with promising early data.